Trials / Sponsors / Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transpla Kidney Transplant Rejection | Phase 2 / Phase 3 | 2024-12-01 |
| Withdrawn | Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Trans Kidney Transplant Rejection | Phase 2 | 2024-12-01 |
| Terminated | Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products Immune Tolerance | — | 2022-05-11 |
| Completed | Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants Kidney Transplant Rejection | Phase 3 | 2018-03-15 |